Seres Therapeutics Inc (MCRB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | MCRB | BMY | AMGN | GILD | REGN |
| Company | Seres Therapeutics Inc | Bristol-Myers Squibb Company | Amgen Inc | Gilead Sciences Inc | Regeneron Pharmaceuticals |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 0.6390 | 49.16 | 272.14 | 67.09 | 905.66 |
| High | 0.6937 | 49.47 | 273.81 | 67.68 | 912.74 |
| Low | 0.6288 | 48.96 | 271.05 | 67.07 | 905.66 |
| Last | 0.6895 | 49.40 | 272.92 | 67.41 | 906.37 |
| Change | +0.0649 | +0.26 | +1.01 | +0.46 | +6.21 |
| % Change | +10.39% | +0.53% | +0.37% | +0.69% | +0.69% |
| Volume | 1,832,986 | 1,473,872 | 356,383 | 1,158,984 | 64,354 |
| 20-Day Average Volume | 3,899,909 | 10,564,309 | 2,108,248 | 6,126,177 | 428,206 |
| Previous Close | 0.6246 | 49.14 | 271.91 | 66.95 | 900.16 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.6940 | 50.57 | 271.94 | 69.36 | 929.20 |
| 20-Day Raw Stochastic | 51.16% | 25.44% | 42.96% | 19.95% | 21.04% |
| 20-Day Relative Strength | 41.78% | 43.61% | 47.82% | 35.35% | 40.26% |
| Weighted Alpha | -88.72 | -24.97 | +10.96 | -20.11 | +14.22 |
| Today's Opinion | 100% Sell | 88% Sell | 40% Sell | 100% Sell | 24% Buy |
| Previous Opinion | 100% Sell | 88% Sell | 40% Sell | 100% Sell | 24% Buy |
| Last Month's Opinion | 100% Sell | 24% Sell | 8% Buy | 88% Sell | 80% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +7.15% since 04/16/24 | +2.28% since 04/16/24 | +2.64% since 04/16/24 | +0.27% since 04/16/24 | +1.62% since 04/16/24 |
| Low | 0.5400 on 04/19/24 | 47.62 on 04/18/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 891.46 on 04/19/24 |
| High | 0.6937 on 04/23/24 | 49.56 on 04/22/24 | 273.80 on 04/23/24 | 67.68 on 04/23/24 | 920.73 on 04/19/24 |
| 1-Month | |||||
| %Chg | -11.34% since 03/22/24 | -4.95% since 03/22/24 | -1.27% since 03/22/24 | -7.05% since 03/22/24 | -6.06% since 03/22/24 |
| Low | 0.5400 on 04/19/24 | 47.62 on 04/18/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 890.43 on 04/16/24 |
| High | 0.8200 on 03/25/24 | 54.47 on 03/28/24 | 288.57 on 03/28/24 | 73.87 on 03/28/24 | 976.75 on 03/27/24 |
| 3-Month | |||||
| %Chg | -43.67% since 01/23/24 | -1.52% since 01/23/24 | -12.02% since 01/23/24 | -15.09% since 01/23/24 | -4.82% since 01/23/24 |
| Low | 0.5400 on 04/19/24 | 47.58 on 02/06/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 890.43 on 04/16/24 |
| High | 1.2600 on 01/29/24 | 55.03 on 03/13/24 | 329.72 on 02/05/24 | 81.06 on 01/25/24 | 998.33 on 02/28/24 |
| 6-Month | |||||
| %Chg | -55.45% since 10/23/23 | -11.86% since 10/23/23 | -0.15% since 10/23/23 | -12.98% since 10/23/23 | +14.21% since 10/23/23 |
| Low | 0.5400 on 04/19/24 | 47.58 on 02/06/24 | 249.70 on 10/31/23 | 65.90 on 04/18/24 | 769.19 on 10/27/23 |
| High | 2.0500 on 01/09/24 | 56.77 on 10/25/23 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 998.33 on 02/28/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 94,320 | 99,594,944 | 145,845,984 | 83,357,904 | 98,803,360 |
| Shares Outstanding, K | 151,009 | 2,026,759 | 536,376 | 1,245,077 | 109,762 |
| Annual Sales | 126,330,000 | 45,006,000,000 | 28,190,000,000 | 27,116,000,000 | 13,117,200,000 |
| Annual Net Income | -113,720,000 | 8,025,000,000 | 6,717,000,000 | 5,665,000,000 | 3,953,600,000 |
| Last Quarter Sales | 60,000 | 11,477,000,000 | 8,196,000,000 | 7,114,000,000 | 3,434,300,000 |
| Last Quarter Net Income | -41,250,000 | 1,762,000,000 | 767,000,000 | 1,429,000,000 | 1,159,600,000 |
| 60-Month Beta | 2.24 | 0.39 | 0.58 | 0.19 | 0.11 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.32 on 03/05/24 | 1.70 on 02/02/24 | 4.71 on 02/06/24 | 1.72 on 02/06/24 | 11.86 on 02/02/24 |
| Latest Earnings Date | 05/14/24 | 04/25/24 | 05/02/24 | 04/25/24 | 05/02/24 |
| Most Recent Dividend | N/A | 0.600 on 04/04/24 | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A |
| Next Ex-Dividends Date | N/A | 04/04/24 | 05/16/24 | 03/14/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 6.52 | 14.42 | 9.93 | 23.86 |